Suppliers / Cambrex

Cambrex

United States Updated 9 July 2026

Cambrex is an API manufacturer based in United States. It appears in 3 regulatory filings across 1 regulator, without an active US DMF or CEP on file.

0
active US DMFs
0
valid CEPs
0
registered plants
3
filings across 1 regulators

What they file, and where

Molecule Regulators Docs
Hydrochlorothiazide SFDA (Saudi Arabia) 1
Midazolam SFDA (Saudi Arabia) 1

Also appears on these molecule pages

Hydrochlorothiazide API Midazolam API

Filings and GMP by regulator

Regulator Filings GMP certificates
MINSA (CR) 3 None

Questions about Cambrex

Does Cambrex hold a US DMF or a CEP?
No active US drug master file or valid CEP is on record for Cambrex. It does have 3 filings with one regulator, so it is registered, just not with the two strong registers buyers usually screen on.
What does Cambrex make?
2 molecules are on record against Cambrex, including Hydrochlorothiazide and Midazolam. Each links through to that molecule's full manufacturer list.
Where does Cambrex file?
Filings are on record with MINSA (CR), 3 in total.

Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.

Comparing suppliers?

Choose your molecules and target markets. Cambrex comes back tiered against every other supplier able to file there.

Start for free
No sales call.

Comparable suppliers

Cambrex Profarmaco Milano shares 2 molecules Apitoria Pharma shares 1 molecule Alembic Pharmaceuticals shares 1 molecule Zydus Lifesciences shares 1 molecule Ipca Laboratories shares 1 molecule

Ranked by shared active ingredients where we have them, otherwise by country and comparable credentials.

Sources on this page

FDA
Drug master files, establishment registration, inspection classifications
EDQM
Certificates of suitability